search
feedback
links
sitemap

home
The Society of the Plastics Industry
about SPI
about the industry
issues and public policy
outreach and education
business development

General Counsel's Report To The Society of The Plastics Industry, Inc.'s Food, Drug, and Comestics Packaging Materials Committee

June 19 - 20, 2001
Jerome H. Heckman
Ralph A. Simmons

INTRODUCTION

Ladies and Gentlemen:

We are pleased to present this report on the status of matters in which we have been involved or which we have monitored on behalf of The Society of the Plastics Industry, Inc.'s (SPI's) Food, Drug, and Cosmetic Packaging Materials Committee (FDCPMC) since the November 30-December 1, 2000 meeting of the Committee.

TABLE OF CONTENTS

HHS Continues to Search for New FDA Commissioner

FDA Implements Organizational Changes

Members of Congress Continue to Push for a Single Food Safety Agency

Panel Recommends More Study on Long-Term Effects of Alleged Endocrine Disruptors

Concern Over Mad Cow Disease Leads to USDA Ban on Imports of Animal Protein Products, Tallow Derivatives Probably Exempt

ACGIH Proposes Designation of "Suspected Human Carcinogen" for Mineral Oil Mists

FDA Publishes Final Regulation on Use of Packaging in E-Beam and X-Ray Irradiation of Meat and Poultry; FDA Movement Toward Irradiation Testing Protocols Raises Concerns

Food Irradiation Continues to Be a Controversial, Important Topic

FDA Releases its Biotech Proposal

EU Study Recommends Incentives for "Green" Products; U.S. Federal and State Legislative Proposals Seek to Reduce Environmental Impact of Packaging

NSF Offers Continuation of USDA Product Certification Programs

1. HHS Continues to Search for New FDA Commissioner

Responding to rumors that it may take up to a year to name a new Food and Drug Administration (FDA) Commissioner, Health and Human Services (HHS) Secretary Tommy Thompson announced this past April that he hopes to name the new commissioner as soon as possible.  The last time it took two years to name a new commissioner, and sources say that the Bush Administration does not want that much time to pass this go-around.

Sources also say that one candidate has been through the first round of interviews.  Numerous names are being floated as potentials for the position, but Michael Friedman is rumored to be the front runner.  Friedman held various positions at FDA in the late 1990s, including acting commissioner in 1997 and 1998.  He currently is vice president for research and development at Pharmacia Corp.

Dr. Bernard Schwetz, the former acting deputy commissioner of the FDA, took over as the acting head of the Agency following former Commissioner Jane Henney’s resignation.  Dr. Schwetz served as acting deputy commissioner from 1999 to January of this year. Previously, he had served as a senior advisor for science at FDA and as a director of the National Center for Toxicological Research in Jefferson, Arkansas.

Thompson also plans to make changes to how the Agency is run, with an eye for easing the regulatory process.  At a recent summit on privacy regulation in Washington, D.C., Thompson announced his plans to review all health care regulations and dispense with those he considers overly burdensome.  He also is seeking industry’s help in identifying those regulations, and the National Food Processors Association (NFPA) already has recommended changes to several regulations.  Among the first things NFPA would like Thompson to strike down are food irradiation labeling requirements.  Such a move certainly would meet serious opposition from Public Citizen, which, as we discuss later in this report, strongly supports strict labeling requirements for irradiated foods.

2. FDA Implements Organizational Changes

FDA announced on June 5, 2001, that the reorganization of its Office of Premarket Approval (OPA) will become effective on June 18th.  As we discussed in a recent letter to the Committee, the Agency’s apparent intent in the reorganization is to increase the efficiency of the review process for food-contact materials and direct food additives.  According to the June 5th announcement, a new Office of Food Additive Safety (OFAS) will replace the 10-year-old OPA. However, it is our understanding that the new office will be staffed by many of the same FDA personnel currently working in OPA.

The OFAS will be comprised of four major operational units reporting to the Deputy Director: the Division of Food Contact Substance Notification, the Division of Petition Review, the Division of Biotech & GRAS Notice Review and the Division of Chemistry Research and Environmental Review. The reorganization abolishes the Division of Health Effects Evaluation, which in the past had been responsible for performing toxicological evaluations. Instead, that function has been distributed among the three review-oriented divisions (the Divisions of Food Contact Substance Notification, Petition Review, and Biotech & GRAS Notice Review); these three divisions each will have its own subdivisions for chemistry, toxicology, and regulatory matters.  The fourth unit, the Division of Chemistry Research and Environmental Review, will primarily function as a laboratory research unit, but the environmental scientists grouped there will serve as a resource to the entire OFAS.

In addition to the four operational divisions, the OFAS will have a policy-making division under the Associate Director for Science and Policy. In the past, the policy-making function was handled in a less formal manner by a policy board made up of the division directors and the technical experts necessary to resolve a specific problem. The proposed reorganization also includes an Operations Staff office that, among other things, will be responsible for developing a system for receiving and processing electronic applications.

3. Members of Congress Continue to Push for a Single Food Safety Agency

Despite previous failed efforts, there continues to be a movement on Capitol Hill toward establishing a single food safety agency.  On May 1, 2001, Rep. Rosa DeLauro (D-Conn.) introduced legislation to propose such an agency.  The proposed Safe Food Act of 2001, H.R. 1671, would provide for a new Food Safety Administration (FSA) that would handle the food safety, labeling and inspection functions now being handled by FDA, the U.S. Department of Agriculture, and other agencies.  Rep. DeLauro introduced a similar measure in 1999, but was not successful in moving it through Congress. 

As we have reported to you previously, the General Accounting Office (GAO) has been advocating the creation of a single food agency as a means to reduce the incidence of foodborne illness in the United States.  In a mid-January report, GAO repeated its concerns over the fragmentation of the current food safety system and the need for a risk-based inspection system administered by a single agency.  Although stopping short of directly supporting a single agency, former President Clinton’s Council on Food Safety issued a report on January 19, 2001, indicating that establishment of  a single food safety authority would be disruptive in the short-term, but might be the most efficient long-term solution.  The Bush Administration does not appear to be working in this direction, but the recent shift in power in the Senate may increase the chances for a single agency by enhancing the power of legislators such as Tom Harkin (D-Iowa) who favor this approach.

Many consumer groups, such as the Center for Science in the Public Interest and Safe Tables Our Priority, have endorsed similar proposals.  However, industry groups have expressed opposition to a single food safety agency.  Among their complaints are fears that a single food safety agency would merely become a “super-bureaucracy” which would need to justify its existence by excessive regulation.  As alternatives to consolidating the current system, industry groups in the past have recommended additional research and educational efforts, improved food safety technology, increased inter-agency coordination of food safety activities, and stronger federal leadership.

4. Panel Recommends More Study on Long-Term Effects of Alleged Endocrine Disruptors

The long-awaited National Toxicology Program’s (NTP) Report on alleged endocrine disruptors was released mid-May, but failed to resolve any questions regarding the health effects of the chemicals.  The panel of scientists that reviewed the numerous studies on endocrine disruptors concluded that, while there is "credible evidence" that low doses of bisphenol A, an alleged endocrine disrupting chemical, can have an effect upon test animals, other "credible studies" failed to observe similar low-dose effects.  Thus, they conclude, the chemical deserves greater scrutiny and additional research.

Bisphenol A is permitted by FDA and in other countries around the world for use in making a variety of food packaging materials, such as polycarbonate and can coatings. The substance has a significant history of use in such applications without reported adverse effects.  Nevertheless, in view of the different results among studies of bisphenol A and other chemicals with alleged potential for low dose endocrine effects, the U.S. Environmental Protection Agency (EPA) requested the review of the various studies by a panel convened by NTP, which is part of the National Institutes of Health's National Institute of Environmental Health Sciences. The 36-member panel set out to "establish a sound scientific foundation upon which the U.S. EPA could determine what aspects, if any, of its standard guidelines of reproductive and developmental toxicity testing need to be modified to detect and characterize low-dose effects of endocrine disruptors."

According to the report issued by the peer review panel's Bisphenol A subpanel, "there is credible evidence that low doses of BPA [bisphenol A] can cause effects on specific endpoints. However, due to the inability of other credible studies in several different laboratories to observe low dose effects of BPA, and the consistency of these negative studies, the Subpanel is not persuaded that a low dose effect of BPA has been conclusively established as a general or reproducible finding." In carrying out its review, the panel asked 15 principal investigators of primary research groups active in the field to provide their individual animal data on selected parameters for independent statistical reanalysis. The raw data were drawn from 49 selected studies. In addition, investigators were asked to provide responses to 23 questions relevant to the evaluation of the studies including, for example, animal source and specification, and methods of data analysis. The review, the panel said, "provided an extraordinarily rigorous, open, transparent, and objective evaluation of the scientific evidence showing the presence or absence of low- dose effects of endocrine disrupting agents and an opportunity for participation by all stakeholders."

According to the subpanel that examined Bisphenol A, several studies provided credible evidence of low-dose effects of bisphenol A, including increased prostate weight in male mice and advanced puberty in female mice after in utero exposure. In addition, the panel saw evidence of certain effects that occurred in F344 rats but not in Sprague-Dawley rats. That finding, it said, demonstrates "a clear difference in sensitivity to the estrogenic effects of Bisphenol A in these two strains of rats." Other large studies with "considerable strength and statistical power" found no evidence of a low-dose effect of bisphenol A.  Besides the discrepancies found in the response by different rat strains, the subpanel said that other discrepancies could be attributed to a variety of factors, including different diets with differing background levels of phytoestrogens, differences in dosing regimens, and differences in the housing of the animals. "Data are insufficient to establish the shape of the dose-response curve for bisphenol A in the low dose region, and the mechanism and biological relevance of reported low dose effects are unclear," the subpanel concluded.

Additional research in a number of areas would "clarify uncertainties about low-dose effects of bisphenol A," the subpanel said. They include:

  • additional low-dose studies, including the development and use of sensitive and easily measured molecular endpoints, following in utero or early neonatal exposure to conclusively establish low-dose effects of bisphenol A as a general, reproducible phenomenon;
  • pharmacokinetic data in multiple species and strains of animals to characterize fetal uptake, metabolism, and elimination of bisphenol A and its metabolites;
  • mechanistic data on estrogen receptor occupancy during critical periods of development, effects of specific receptor antagonists, and responses in estrogen- receptor knock-out mice;
  • additional studies on intrauterine position effects;
  • characterization of genetic and epigenetic factors that affect responses to bisphenol A and hormones in general, e.g., factors that lead to strain and species differences in sensitivity;
  • mechanistic studies on the effects of bisphenol A on regulation of transcriptional activity, from gestation through adulthood.


Another subpanel, charged with examining other environmental estrogens, found low- dose effects of nonylphenol, an industrial compound identified in drinking water, including a decrease in the volume of sexually dimorphic nuclei of the preoptic area of the hypothalamus in male rats, an increase in relative thymus weight, and prolonged estrus in females. In contrast, the subpanel found no evidence of low-dose effects of octylphenol, an intermediate for the production of surfactants, in a five-dose multigeneration study in rats.

Thus, the massive undertaking by EPA and NPT left us with little more than what we had prior to the effort:  conflicting toxicological reports and a new suggestion that still more costly, time consuming, and potentially frustrating testing should be undertaken.  One obvious question concerns where the funding for such testing will come from.  Since the low dose theory is counter-intuitive and gives rise to considerable skepticism, it would seem that the burden of proving it should be on the proponents. Meanwhile, in our view, the NTP report indicates that there is not a scientific basis at this point for EPA, FDA, or other regulators to make endocrine effects testing a general requirement for product clearances.

The report is open for public comment until July 16, 2001.  Please let us know whether you find aspects of the report on which the Committee should comment.  We understand that the polycarbonate producers group within the American Plastics Council (APC) is evaluating the report for possible comment.  This Committee, however, also may have issues or interests that should be represented in our own comments, which we certainly would attempt to coordinate with any APC comments.

The report is available on the NTP’s website at http://ntp-server.niehs.nih.gov/.

5. Concern Over Mad Cow Disease Leads to USDA Ban on Imports of Animal Protein Products, Tallow Derivatives Probably Exempt

In response to the problem of bovine spongiform encephalopathy (BSE), commonly known as “mad cow disease,” in certain parts of Europe and elsewhere, the United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) instituted a ban on the importation of all processed animal proteins and certain products derived from these proteins, regardless of species of origin, from countries that are either affected by BSE or that have an unacceptably high risk for BSE.  As we reported to you early this year, APHIS invoked the ban on December 7, 2000,  after the European Union (EU) Scientific Steering Committee found that animal feed which was not derived from ruminants was cross-contaminated with the agent responsible for BSE (the most generally accepted theory is that the agent is a modified form of a normal cell protein known as a prion).  The prohibited products include, but may not be limited to, meat and bone meal, blood meal, fish meal, poultry meal, tankage, offal, fat, glands or any product containing these substances. BSE-affected countries are listed on the APHIS home page at www.aphis.usda.gov.

The ban subsequently was extended to include products that have been "stored, processed, or otherwise associated with a facility located in Europe and Oman." This ban apparently applies only to edible products.  Imports of the products have been allowed only if APHIS can verify that they have not been commingled or cross-contaminated with ruminant products from Europe and Oman. In making the determination, APHIS has been applying the following factors:
  • All steps of processing and storage are carried out in a dedicated foreign facility,
  • The foreign facility should have a cooperative service agreement with APHIS,
  • The facility should demonstrate that material intended for export to the United States was transported in a manner that would prevent cross-contamination with prohibited materials,
  • The foreign facility should allow periodic APHIS inspection, and
  • The facility should supply government certification regarding the dedicated processing facility.


It has been our understanding that the ban does not apply to tallow derivatives, such as fatty acids, that have food-contact applications.  Our contacts at APHIS have indicated that an interim rule to be published “any day” specifically exempts tallow derivatives, because these products are believed to be sufficiently purified to remove all proteins and, thus, the BSE infectious agent.  However, we were cautioned that the rule as originally drafted could be changed to remove this exemption if concerns were raised during the final review process.

With respect to bulk shipments of tallow, we have received conflicting advice from different APHIS officials on whether these are included in the ban.  As we explained in previous letters, it is probable that such shipments will be included, because tallow may contain proteins and could be used in animal feed.  Tallow intended for further processing into the derivatives that might be used in packaging materials, however, may be exempt from the ban, or, if not subject to a blanket exemption, then permitted for import on a case-by-case basis.  The February 9 extension of the ban to products coming from any facility in Europe or Oman probably will not apply to tallow dedicated to production of derivatives because the extension applies only to products for edible applications.

The USDA is not the only agency being pressured to invoke measures to prevent the spread of BSE in this country.  Stating that BSE is “one of the most important public health issues facing the nation,” the House Energy and Commerce Committee requested from FDA details on the Agency’s efforts to prevent the spread of mad cow disease through import controls and restrictions on the use of animal feed.  While the Committee requested an FDA response by April 30, as of mid-May the agency had yet to respond to the request.

Meanwhile, possibly in response to this pressure, FDA recently issued an expanded BSE import alert which cautions ports to be on the lookout for, among other things, food additives derived from ruminant materials.  We are attempting to contact FDA officials to obtain more information on the alert, but are hopeful that the import bulletin would not affect tallow derivatives intended for packaging materials since, in the past, the primary concern has been with non-purified ruminant material most likely to contain active infectious material.

6. ACGIH Proposes Designation of “Suspected Human Carcinogen” for Mineral Oil Mists

The TLV (Threshold Limit Value) Committee of the American Conference of Governmental Industrial Hygienists (ACGIH) recently conducted a review of the current scientific literature on mineral oils and has proposed, based on the results of this review, that mineral oil mists be assigned an "A2 Suspected Human Carcinogen" status.    The proposal was published as a notice of intended change in the 2001 ACGIH-TLV book.  The background documentation, identified as "DDN-034 - Oil mist: Chemical Substance TLV® Draft Documentation, Notice of Intended Change" is available from ACGIH at a cost of $50.00.

ACGIH, as well as the Occupational Safety and Health Administration (OSHA), currently includes in the definition of mineral oils and their mists the following substances:  white mineral oil (considered food-grade), paraffin oil, cutting oil, hydraulic oil, transformer oil, lubricating oil, and others.  Some plastics applications associated with potential generation of oil mists include metalworking and mold making, mist lubrication, mold release agents, oil-lubricating tools, and printing inks.  Acute and chronic exposure to mineral oil mists is regulated by an OSHA permissible exposure limit of 5 mg/m3 as an 8-hour time-weighted average concentration.  Along with the proposal to change the carcinogenicity classification, the ACGIH subcommittee also is proposing that the permissible occupational exposure TLV be lowered to 0.2 mg/m3.

According to ACGIH staff, ACGIH accepts public comments on all of its proposed and final TLVs on an ongoing basis.   However, the TLV Committee plans to meet this summer to make a final recommendation to the ACGIH Board of Directors on a TLV for mineral oil mists.   For comments on the oil mist proposal to be considered by the TLV Committee in making that recommendation, ACGIH staff says that they should be submitted to ACGIH, preferably in electronic form, by June 29, 2001.  If the TLV Committee and the Board vote to proceed, the new TLV and carcinogenicity status become final in 2002.  Please advise us if this is a matter on which you believe the Committee should submit comments.

7. FDA Publishes Final Regulation on Use of Packaging in E-Beam and X-Ray Irradiation of Meat and Poultry; FDA Movement Toward Irradiation Testing Protocols Raises Concerns

Since the Committee’s previous meeting, FDA has acted on several petitions involving the irradiation of food.  Of most significance to the packaging industry, FDA finally acted favorably on the petition to allow food packaged with any of the materials listed under 21 C.F.R. Section 179.45 to be treated with e-beam and x-ray sources of irradiation, in addition to gamma sources.  See 66 Fed. Reg. 10574.  This final rule is helpful in opening up the use of all packaging materials currently cleared in Section 179.45 with e-beam and x-ray sources, which generally are preferred by industry at present, but does not address the problem of the limited types of packaging cleared under Section 179.45. 

By way of background, FDA permits certain types of irradiation as a means to treat specified foods for the purpose of controlling microbes, pathogens, pests, and the maturation of food.  Regulations governing the irradiation of food are found in Title 21 of the Code of Federal Regulations, Part 179, "Irradiation in the Production, Processing and Handling of Food."  Section 179.45 specifies  materials that have been cleared by FDA specifically to package food intended to be irradiated.

Because few food packaging materials are listed in Section 179.45, a number of  companies are attempting to win FDA clearance of additional materials.  To that end, appropriate studies must be conducted to demonstrate the potential for formation and migration of radiolytic byproducts from the packaging materials to the food.  Generally, a company will first determine if radiolytic byproducts are formed as a result of the irradiation process and, if so, it will determine whether these byproducts migrate to food at levels that are considered to be safe.

It should be noted that, in our view, all packaging materials do not need to be listed in Section 179.45 to have a suitable FDA status for holding food during irradiation.  If a material has FDA compliance for contact with food generally, we consider it suitable to hold food for irradiation if it can be demonstrated that no significant change in the potential migrants is caused by irradiation.  Of  course, testing usually is required to support such a conclusion, and appropriate FDA guidance would be helpful to companies in conducting the proper tests.

In this regard, a recent protocol for irradiation testing provided by FDA to certain companies currently seeking FDA clearance of packaging materials for the irradiation of food has raised some significant questions on this issue.  This document, titled “Testing Protocols for Determining Exposure to Radiolysis Products from Packaging Materials Irradiated in Contact with Food,” was provided to us following discussions on the appropriate testing of particular materials for irradiation.  While the document has not yet been cleared by FDA for general release, the Agency is expected ultimately to issue formal guidance on irradiation testing.

The draft document details two different protocols, either of which can be used: a "step-wise" approach, and a "direct migration" approach.  The “step-wise” approach involves irradiation of the packaging material using a range of doses to determine the dose/response curve for the formation of the various radiolytic byproducts, if any.  Once byproducts are identified and their levels in the packaging are determined, it is assumed that 100 percent of the byproducts will migrate into the contacted food.  If the calculated level of any byproducts in the food is too high to evaluate without additional toxicity studies -- 0.5 parts per billion (ppb) in the diet -- migration studies must be carried out on the irradiated packaging to determine the actual level of the byproducts in the contacted food.  Again, the dietary level for any migrating byproducts must be below 0.5 ppb if toxicity testing is to be avoided.  A level higher than 0.5 ppb, of course, triggers the usual prescribed series of toxicology studies to demonstrate the safety of the packaging materials under these conditions of use.

Also included in the “step-wise” approach is the requirement to carry out the same studies on a “check sample,” which is a standard reference polymer obtained from the National Institute for Standards and Technology (NIST).  The results obtained on the standard reference polymer by the company will be compared to the results obtained by FDA on the same standard reference polymer, as a way of verifying that the irradiation studies were carried out correctly.    

The “direct migration" approach essentially goes directly to the migration studies, after a quick screen to identify any low-molecular-weight radiolytic byproducts. This approach does not require the use of a “check sample.”  Rather, validation of the testing is done with the use of spiked “surrogate” chemicals to represent any byproducts found to migrate into contacted food.

Using either of FDA’s two draft recommended testing protocols will involve a substantial amount of work that is very costly to conduct in terms of both time and money.  On behalf of certain companies, we have commented to FDA on ways to simplify and clarify the recommended testing.  We currently are drafting additional comments and suggestions on the draft test procedures and plan to submit them to FDA before the protocol is finalized in the form of a guidance document.

8. Food Irradiation Continues to Be a Controversial, Important Topic

As we have reported in previous letters, FDA published an advance notice of proposed rulemaking (ANPR) in the Federal Register in February 1999 soliciting comments on revisions to labeling requirements for irradiated foods. (64 Fed. Reg. 7834 (February 17, 1999)). In response, FDA received over 4,500 comments.  Early this year, and in the face of Congressional pressure to finalize its rules on irradiation labeling, the Agency reported that development of irradiation labeling rules has been stalled by an apparent lack of consensus over alternative language for disclosure statements about irradiation processing.  The Agency referred to the voluminous comments it received, most of which supported special labeling for irradiated foods but did not specify preferred labeling requirements.

In the meantime, Public Citizen is lobbying Congress to ensure that FDA does not authorize less alarming irradiation labeling options.  The group is particularly concerned that FDA will allow use of such terms as “cold pasteurized,” which it claims may mislead consumers into believing that an irradiated food has not been irradiated.

Public Citizen also is urging FDA to deny pending food additive petitions that seek approval of food irradiation, and continues to voice its concern that FDA has approved petitions involving irradiation of foods without conducting toxicological tests.  Of particular concern to Public Citizen is the “ready to eat” petition, which would widely broaden the scope of foods allowed to be irradiated.  The group has called upon FDA to conduct toxicological tests on the foods that are subjects of this petition (cooked poultry products, refrigerated and frozen entrees, frozen sandwiches, and some prepared fruits and vegetables).  FDA action on the “ready-to-eat” petition has been rumored to be imminent for several months now. 

Although Public Citizen continues to urge FDA to reject petitions involving the irradiation of food, representatives from companies that have developed x-ray, e-beam and gamma irradiation say that they are ready to begin servicing the food industry on a mass scale once FDA approves broader use of the technology. 

On an international level, despite strong opposition, the European Commission is planning to expand the list of food products that can be treated with irradiation.  If approved by the full Commission, three additional groups of products will be allowed to be treated with irradiation:  (1) herbs, dried fruit and flakes, and germs of cereals; (2) mechanically recovered chicken meat, chicken offal, egg white and gum arabic; and (3) frog legs and peeled shrimp.  Both the European Office of Consumers Union and the European Community of Consumer Cooperatives filed comments criticizing the proposal.  As expected, many other consumer advocacy groups in the EU strongly oppose the proposal as well.  Even some food industry associations filed comments against the proposal, likely due to fear that consumers will reject their products if they suspect the products were treated with irradiation.

Meanwhile, Health Canada has approved proposals for irradiating ground beef and poultry, but the proposals still face several hurdles before companies can begin irradiating meat.  The approvals still must be ratified by the Canadian cabinet and posted in the Canada Gazette for public comment. Canada currently allows irradiation of certain food products, including onions, flour, and spices.

Finally, during its March 12 – 16, 2001 meeting, the Codex Alimentarius Committee on Food Additives and Contaminants approved a proposal to remove the current 10 kiloGray dose cap for food irradiation.  The full Codex Commission will consider adopting the proposal during its biennial meeting in July.  As expected, Public Citizen immediately opposed the proposal, arguing that chemical changes to food caused by high-dose irradiation have not been studied adequately.

9. FDA Releases its Biotech Proposal

The new FDA proposal for premarket notice of bioengineered foods was published in the Federal Register on January 18, 2001, together with a notice of availability of a draft guidance on voluntary labeling of these products.  The proposal and draft guidance, while satisfactory to industry, did not receive a warm welcome from Congress and certain public interest groups.  The proposed rule establishes a procedure for voluntary consultation to be followed by a mandatory notification to the Agency before biotech foods can be legally marketed, and the draft guidance keeps labeling of biotech products purely voluntary.

Premarket Notification Procedure Mandatory

The primary thrust of the proposed rule is the requirement for a submission of information to the Agency on all biotech foods at least 120 days prior to their commercial distribution.  It does not appear that food additives, and packaging materials that are food additives, would be subject to the requirement.  If FDA does not object to the marketing of the foods within that time period, they are legally marketable.  This new “Premarket Biotechnology Notice” (PBN) would be mandatory for any food derived from a genetically modified plant, including those modified to contain a pesticidal substance, whether it is to be used for human or animal consumption.  Bioengineered foods that have been previously approved by FDA (and are already on the market) will be excluded from the notification requirement.

 Biotech Labeling Still Voluntary

 FDA repeated in the Federal Register the Agency’s existing position that there is “no basis for concluding that bioengineered foods differ from other foods in any meaningful or uniform way, or that, as a class, foods developed by new techniques present any different or greater safety concern than foods developed by traditional plant breeding.”

 The Agency continues to require that biotech foods containing unexpected allergens or significantly different nutritional properties bear appropriate disclosures on their labels, as the main concern of FDA remains to prevent false or misleading labeling as opposed to requiring special labeling of biotech foods.  Consequently, labels containing statements such as “GMO free” are not currently considered acceptable by FDA, as the complete absence of bioengineered material in food products is difficult to assess, and the label might be misleading in implicitly conveying the message that a food is of superior quality if it does not contain such material.

Products that do contain bioengineered material do not have to be labeled differently from other products (except for the cases cited above). Federal statutes mandate that the labeling of food must reveal all facts that are “material,” and FDA concluded in the Federal Register publication that “the use, or absence of use, of bioengineering in the production of a food is not a fact that is material either with respect to consequences resulting from the use of the  food or due to representations on the labeling.”  It is therefore up to the manufacturers and distributors to decide whether they want to add a biotech mention in the labeling of their product.

10. EU Study Recommends Incentives for “Green” Products; U.S. Federal and State Legislative Proposals Seek to Reduce Environmental Impact of Packaging

The European Commission (EC) recently issued a green paper on “Integrated Product Policy,” an approach to environmental policy that seeks to make products more environmentally friendly. This green paper proposes a strategy to strengthen and refocus product-related environmental policies to promote the development of a market for “greener” products, and requests public comment on the strategies discussed in the Paper.  The full Paper can be viewed at http://europa.eu.int/comm/environment/ipp/0168_en.pdf. 

The Paper states that the most effective way to encourage the development of “greener” products is by “getting the price right” to encourage consumers to purchase the products.  It advocates lowering or eliminating the value added tax for products carrying the EU’s Eco-label, using “state aid” to financially support the development of environmentally preferable products, eliminating subsidies on products that are not environmentally friendly, and making it mandatory for governments to purchase “green” products.

In the U.S., further recycling initiatives are being sought by some federal and state legislators.  In early May, Rep. Lynn Rivers (D-Mich) introduced a bill that would establish a national beverage container recycling program.  The bill, entitled the National Beverage Container Reuse and Recycling Act of 2001, would amend the Solid Waste Disposal Act to provide consumers with a 10-cent refund for the return of empty, unbroken containers.  It would apply to a wide variety of beverage containers, including those made of metal, glass, and plastic, that have a capacity of up to one gallon, and that hold wine coolers, sparkling or carbonated water, fruit juice, beer, soft drinks, and other beverages.  The bill seems certain to attract strong opposition from the food industry.

On the state level, a bill has been introduced in California that would require a plastic pollution prevention fee to be paid by companies packaging products in plastic containers if a 50% statewide plastics recycling rate is not attained by January 1, 2005.  The fee would be equal to the difference between the scrap value and the cost of recycling for each resin type.  Currently, California’s plastics recycling law requires a 25% statewide recycling rate, but food and beverage containers are exempt.  The new bill does not contain an exemption for food and beverage containers.  It is sponsored by state Senator Wesley Chesbro, who has previously proposed toughening California’s existing plastics recycling law, including ending the exemption for food and beverage containers.

Efforts also continued in Hawaii to pass container deposit legislation during the Spring session.  Companion bills were introduced in both the House and the Senate.  However, the bill did not make it out of Committee before the Hawaii legislature adjourned.  In Iowa there is talk of expanding the current deposit system beyond the current soft drink and beer to include other beverages such as water.  In the past, these proposals have not gone very far.  We are monitoring these situations and will continue to update the Committee on any developments.

11. NSF Offers Continuation of USDA Product Certification Programs

The NSF International (NSF) has recently developed two programs applicable to the use of products in federally inspected meat and poultry facilities.  In the past, the Food Safety and Inspection Service (FSIS), a branch of the USDA, required federally inspected facilities to use only those nonfood compounds and proprietary substances (lubricants and sanitizers, for example) that had been approved under a USDA authorization program.  FSIS also formally reviewed and approved the design of equipment used in meat and poultry facilities.

USDA discontinued both of these programs in an effort to eliminate “command and control” requirements that were contrary to the Agency’s current Hazard Analysis and Critical Control Point (HACCP) philosophy.    USDA no longer considers its lists of accepted equipment and substances to be effective and now requires facility operators to determine whether a particular product is acceptable under the facility’s HACCP plan.  Under HACCP, meat and poultry establishments must identify and manage critical control points, areas where chemical, physical, and microbial contamination may occur.  Once these points are identified, the processor must reduce contamination risk and maintain documentation describing any corrective actions taken.

With the elimination of the prior approval programs, the regulated industry no longer had a readily available list of products acceptable for use in their facilities.  Responding to requests from the regulated industry for assistance in identifying acceptable products, NSF developed a registration program for nonfood substances and assisted in the development of a certification standard for equipment.

Proprietary Substances and Nonfood Compounds

Under NSF’s registration program for proprietary substances and nonfood compounds, manufacturers of substances used in federally inspected meat and poultry processing facilities voluntarily register their products with NSF.  This program is intended to provide meat and poultry processors a list of products which have been found to be acceptable for use in federally inspected facilities.  Proprietary substances include antifoaming agents, marking agents, poultry and hog scald media, and fruit and vegetable washing products.  Nonfood compounds are products that are used in and around food processing areas, but are not intended for direct contact with food.  Such substances include maintenance and cleaning chemicals, sanitizers, lubricants, and water treatment chemicals.

NSF’s program essentially mirrors the requirements, categories, and product designations from the previous USDA program.  In fact, to begin the program, NSF included all of the substances previously authorized by USDA in their list of “approved” compounds.  The NSF program also allows ingredient manufacturers to participate in the program by registering their active ingredients and other additives.  Although somewhat similar to a master file under the former USDA program, ingredient manufacturers now may provide formulation information on a confidential basis to NSF and receive the additional benefit of having their product included in a separate listing for acceptable ingredients.  This should allow finished product manufacturers to choose ingredients from a list of products that have already been reviewed by NSF and may result in a streamlined review process for finished products.

In addition to products included on the former USDA list, manufacturers may now “register” new products with NSF.  The registration process includes a formulation and label review, determination of appropriate use classification and category codes.  To distinguish substances that were previously listed by USDA and those that are NSF “registered” in the official Internet listing of these products, NSF uses different colors for the two types of listing.  The online listing is available at http://www.nsf.org/usda.  Manufacturers of registered products may include the NSF registration mark on their product labels.

Equipment

Working closely with USDA’s Agriculture Marketing Service and the regulated industry, NSF also has developed a voluntary certification standard for equipment used in federally inspected meat and poultry facilities.  AMS has adopted the ANSI/NSF/3-A standard as the standard to be applied in the AMS voluntary certification program for equipment, which was established at the request of industry to fill the void created by the end of the USDA FSIS program.  This certification program became effective on January 8, 2001. 

When a manufacturer files an application for certification under this program, USDA specialists will review the design, inspect equipment, and determine if the equipment complies with the performance criteria in the ANSI/NSF/3-A standard.  Upon completion of the review, the product may be marked with official identification symbol to indicate that the equipment has been “accepted” by USDA.  In addition, USDA will include the product on its Internet listing of accepted products, available at http://www.ams.usda.gov.

Although third parties, such as NSF, also may certify food processing equipment to the ANSI/NSF/3-A standard, products certified by third parties may not include the USDA “accepted equipment” mark nor will they be included in USDA’s list of accepted products.

 

 

Back to Top

More About SPI:   Vision and Mission . Membership . Business Units . Regional Offices . News and Publications . Calendar of Events . Terms and Conditions of Use


SPI Logo© Copyright 2005 The Society of the Plastics Industry.